Paratek Pharmaceuticals, Inc. PRTK

Set alert

Price alert · PRTK

All alert types
2.23 +2.23 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
127.83M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-27.50
Beta
1.71
Short ratio
1.47
Inst. own
52.56%
Dividend
0.00
Ex-div date
Oct 30, 2014
Earnings
Nov 2, 2023
50-d avg
1.98
200-d avg
2.19
1y target
3.10

3M chart

Chart tools
Interval

Events in this range
  • Jul 10, 2023Rating: HC Wainwright & Co. · Neutral → Neutral
  • Aug 3, 2023Earnings: —; estimate -0.31; surprise —%
Signals (14)
NameDateAgo
MACD: Buy SignalSep 21, 20233 years ago
SMA: BullishSep 20, 20233 years ago
SMA: BullishSep 20, 20233 years ago
MACD: Sell SignalSep 13, 20233 years ago
SMA: BullishSep 5, 20233 years ago
MACD: Buy SignalSep 5, 20233 years ago
SMA: BearishSep 1, 20233 years ago
MACD: Sell SignalSep 1, 20233 years ago
MACD: Buy SignalAug 30, 20233 years ago
SMA: BullishAug 24, 20233 years ago
SMA: BullishAug 24, 20233 years ago
SMA: BearishAug 21, 20233 years ago
SMA: BearishAug 21, 20233 years ago
SMA: BullishAug 18, 20233 years ago

Analyst view

Consensus: buy

Buy
Price target (mean) 3.10 +39.0% upside
Target (low)
2.15
Target (mean)
3.10
Target (high)
5.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
  • Strong buy7
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 10
  • 1 month ago 3
  • 2 months ago 3
  • 3 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PRTK analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.31-0.33 – -0.30-0.33+6.1%33.85M+14.2%3
Next quarter-0.25-0.26 – -0.24-0.38+34.2%38.12M+26.2%3
Current year-0.94-1.11 – -0.65-1.17+19.7%154.80M-3.4%3
Next year-0.08-0.64 – 0.44-0.94+91.5%221.33M+43.0%3

Upgrades and downgrades

The latest rating changes

PRTK analyst upgrades and downgrades
DateFirmActionFromTo
Jul 10, 2023HC Wainwright & Co.ReiteratedNeutralNeutral
Jun 7, 2023HC Wainwright & Co.DowngradeBuyNeutral
Jun 7, 2023JefferiesDowngradeBuyHold
Mar 20, 2023HC Wainwright & Co.Maintained—Buy
May 6, 2022HC Wainwright & Co.Maintained—Buy
Mar 17, 2022HC Wainwright & Co.Maintained—Buy
Feb 10, 2022WBB SecuritiesUpgradeBuyStrong Buy
Nov 9, 2021HC Wainwright & Co.Maintained—Buy
Jun 21, 2021HC Wainwright & Co.Maintained—Buy
Apr 23, 2021WBB SecuritiesUpgradeSpeculative BuyBuy
Mar 2, 2021JefferiesInitiated—Buy
Nov 9, 2020HC Wainwright & Co.Maintained—Buy
Aug 11, 2020HC Wainwright & Co.Maintained—Buy
Aug 11, 2020SVB LeerinkMaintained—Outperform
Jan 8, 2020WBB SecuritiesInitiated—Speculative Buy
Jan 2, 2019Canaccord GenuityInitiated—Buy
Aug 27, 2018Bank of AmericaInitiated—Neutral
Mar 2, 2018H.C. WainwrightMaintainedBuyBuy
Mar 2, 2018Raymond JamesDowngradeStrong BuyOutperform
Oct 24, 2017GuggenheimInitiated—Buy
May 19, 2017Raymond JamesInitiated—Strong Buy
Apr 4, 2017WedbushReiterated—Outperform
Jun 17, 2016Ladenburg ThalmannMaintained—Buy
Mar 29, 2016Cantor FitzgeraldInitiated—Buy
Feb 29, 2016H.C. WainwrightInitiated—Buy
Jul 22, 2015Gabelli & Co.Initiated—Buy
May 27, 2015BTIG ResearchInitiated—Buy
May 15, 2015Leerink SwannInitiated—Outperform
May 12, 2015Cantor FitzgeraldInitiated—Buy
May 11, 2015GuggenheimInitiated—Buy